Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
The Journal of Clinical Endocrinology and Metabolism|February 25, 2011
The genetics of bone loss: challenges and prospectsBraxton D Mitchell, Laura M Yerges-Armstrong
The Gerontologist|June 10, 2015
The Interplay of Genetics, Behavior, and Pain with Depressive Symptoms in the ElderlyN Jennifer Klinedinst, Barbara Resnick, Laura M Yerges-Armstrong, et al.
Bone|June 29, 2013
E2F1 effects on osteoblast differentiation and mineralization are mediated through up-regulation of frizzled-1Shibing Yu, Laura M Yerges-Armstrong, Yanxia Chu, et al.
The Biochemical Journal|November 5, 2014
AP2 suppresses osteoblast differentiation and mineralization through down-regulation of Frizzled-1Shibing Yu, Laura M Yerges-Armstrong, Yanxia Chu, et al.
Plos One|October 4, 2016
Transcriptional Regulation of Frizzled-1 in Human Osteoblasts by Sp1Shibing Yu, Laura M Yerges-Armstrong, Yanxia Chu, et al.
Molecular Endocrinology (Baltimore, Md.)|March 11, 2016
Assignment of Functional Relevance to Genes at Type 2 Diabetes-Associated Loci Through Investigation of β-Cell Mass DeficitsElizabeth A O'Hare, Laura M Yerges-Armstrong, James A Perry, et al.
The Journal of Clinical Endocrinology and Metabolism|October 10, 2013
Decreased bone mineral density in subjects carrying familial defective apolipoprotein B-100Laura M Yerges-Armstrong, Haiqing Shen, Kathleen A Ryan, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|February 21, 2016
Gene Expression Differences Between Offspring of Long-Lived Individuals and Controls in Candidate Longevity Regions: Evidence for PAPSS2 as a Longevity GeneLaura M Yerges-Armstrong, Sumbul Chai, Jeffery R O'Connell, et al.
Molecular Genetics and Metabolism Reports|February 4, 2017
Sex-specific effects of serum sulfate level and <i>SLC13A1</i> nonsense variants on DHEA homeostasisChristina G Tise, Leslie E Anforth, Albert E Zhou, et al.
Journal of Clinical Pharmacology|April 9, 2014
Effectiveness of clopidogrel dose escalation to normalize active metabolite exposure and antiplatelet effects in CYP2C19 poor metabolizersRichard B Horenstein, Rajnikanth Madabushi, Issam Zineh, et al.
Pageof 8